$SESN I've seen several posts lately comparing the CR of BCG against Vicinium. The CR of Vicinium was for patients that BCG failed. The CR of BCG is 1st line treatment. They both activate the body's own immune system so it could be argued that if Vicinium worked when BCG didn't that is could produce superior or equal results as a 1st line. The studies showed that Vicinium worked better for patients with less treatment with BCG.Its all speculation at this point but Vicinium will be available to the patients who aren't considered high risk enough to be treated with BCG due to the guidelines that they are using due to the BCG shortage so it won't be speculation for long.